335 related articles for article (PubMed ID: 27502600)
41. Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases.
Chiang HL; Tung CH; Huang KY; Hsu BB; Wu CH; Hsu CW; Lu MC; Lai NS
Medicine (Baltimore); 2021 Sep; 100(37):e27230. PubMed ID: 34664863
[TBL] [Abstract][Full Text] [Related]
42. Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity.
Fornaro M; Girolamo F; Cacciapaglia F; Carabellese G; Bizzoca R; Scioscia C; Coladonato L; Lopalco G; Ruggieri M; Mastrapasqua M; Fari G; D'Abbicco D; Iannone F
Clin Exp Immunol; 2023 Dec; 214(1):94-102. PubMed ID: 37280166
[TBL] [Abstract][Full Text] [Related]
43. [Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits/dermatomyosits].
Chen F; Shu XM; Wang DX; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):204-8. PubMed ID: 22516988
[TBL] [Abstract][Full Text] [Related]
44. Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis.
Samsonov MY; Nassonov EL; Tilz GP; Geht BM; Demel U; Gurkina GT; Shtutman VZ; Guseva AG; Wachter H; Fuchs D
Br J Rheumatol; 1997 Jun; 36(6):656-60. PubMed ID: 9236675
[TBL] [Abstract][Full Text] [Related]
45. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
[TBL] [Abstract][Full Text] [Related]
46. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
47. Serum C1q Concentration Positively Correlates with Erythrocyte Sedimentation Rate in Polymyositis/Dermatomyositis.
Li L; Chen J; Chen S; Liu C; Zhang F; Li Y
Ann Clin Lab Sci; 2019 Mar; 49(2):237-241. PubMed ID: 31028070
[TBL] [Abstract][Full Text] [Related]
48. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.
Muro Y; Hosono Y; Sugiura K; Ogawa Y; Mimori T; Akiyama M
Arthritis Res Ther; 2015 Mar; 17(1):57. PubMed ID: 25885224
[TBL] [Abstract][Full Text] [Related]
49. Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients.
Peng JM; Du B; Wang Q; Weng L; Hu XY; Wu CY; Shi Y
PLoS One; 2016; 11(4):e0154441. PubMed ID: 27115138
[TBL] [Abstract][Full Text] [Related]
50. Association of systemic and thyroid autoimmune diseases.
Biró E; Szekanecz Z; Czirják L; Dankó K; Kiss E; Szabó NA; Szucs G; Zeher M; Bodolay E; Szegedi G; Bakó G
Clin Rheumatol; 2006 Mar; 25(2):240-5. PubMed ID: 16247581
[TBL] [Abstract][Full Text] [Related]
51. Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
Herbert MK; Stammen-Vogelzangs J; Verbeek MM; Rietveld A; Lundberg IE; Chinoy H; Lamb JA; Cooper RG; Roberts M; Badrising UA; De Bleecker JL; Machado PM; Hanna MG; Plestilova L; Vencovsky J; van Engelen BG; Pruijn GJ
Ann Rheum Dis; 2016 Apr; 75(4):696-701. PubMed ID: 25714931
[TBL] [Abstract][Full Text] [Related]
52. Features of polymyositis and dermatomyositis in the elderly: a case-control study.
Pautas E; Chérin P; Piette JC; Pelletier S; Wechsler B; Cabane J; Herson S
Clin Exp Rheumatol; 2000; 18(2):241-4. PubMed ID: 10812498
[TBL] [Abstract][Full Text] [Related]
53. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
54. The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients.
Shi Z; Meng Z; Han Y; Cao C; Tan G; Wang L
Lupus; 2018 Apr; 27(4):621-627. PubMed ID: 29058991
[TBL] [Abstract][Full Text] [Related]
55. CCL13 is a promising diagnostic marker for systemic sclerosis.
Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
Br J Dermatol; 2010 Feb; 162(2):332-6. PubMed ID: 19747218
[TBL] [Abstract][Full Text] [Related]
56. Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis.
Hu C; Wu C; Yang E; Huang H; Xu D; Hou Y; Zhao J; Li M; Xu Z; Zeng X; Wang Q
Clin Rheumatol; 2019 Aug; 38(8):2181-2187. PubMed ID: 30888566
[TBL] [Abstract][Full Text] [Related]
57. Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?
Dantas AT; Marques CD; da Rocha Junior LF; Cavalcanti MB; Gonçalves SM; Cardoso PR; Mariz Hde A; Rego MJ; Duarte AL; Pitta Ida R; Pitta MG
Dis Markers; 2015; 2015():519638. PubMed ID: 26078482
[TBL] [Abstract][Full Text] [Related]
58. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
[TBL] [Abstract][Full Text] [Related]
59. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.
Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M
PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353
[TBL] [Abstract][Full Text] [Related]
60. [Levels of acute-phase-reactants in patient with dermatomysitis and its correlations with IL-6 and dermatomyositis disease activity].
Yang M; Liang Y; Cai YF; Lin H; Xie QB; Yin G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):814-7. PubMed ID: 24325119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
